Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Global and Regional Geographical Prevalence of Depression in Gastric Cancer: A Systematic Review and Meta-Analysis Publisher Pubmed



Kouhestani M1 ; Ahmadi Gharaei H2 ; Fararouei M3 ; Hosienpour Ghahremanloo H4 ; Ghaiasvand R5 ; Dianatinasab M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Health Management and Economics, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Health, Faculty of Public Health, Social Determinants of Health Research Center, Gonabad University of Medical Sciences, Gonabad, Iran
  3. 3. Department of Epidemiology, Faculty of Public Health, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Department of Epidemiology, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
  6. 6. Department of Epidemiology, Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahrud, Iran

Source: BMJ Supportive and Palliative Care Published:2020


Abstract

Background Substantial uncertainty exists about the prevalence of depression in patients with gastric cancer. We aimed to summarise the global and regional pooled prevalence of depression among patients with gastric cancer. Method Up to February 2020, we searched PubMed/MEDLINE, Embase, Scopus, Web of science (ISI) and PsychINFO to identify published studies on the prevalence of depression among patients with gastric cancer. The study selection procedure was in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We estimated the prevalence of depression in gastric cancer patients using a random-effect pooled estimate analysis approach with subgroup analysis based on WHO regions, and methods of depression measurement. Results Totally, we retrieved 3781 studies from the previously mentioned databases, of which 18 (12 cross-sectional and 6 cohort studies in design) met the eligibility criteria, which were published from 2001 to 2017 in different regions. The total sample size of the included studied contained 4709 patients with gastric cancer, of which 1885 cases were diagnosed with depression. The pooled prevalence of depression among gastric cancer patients was 37%(95% CI: 26% to 48%). Subgroup analysis showed that the highest prevalence of depression was in Eastern Mediterranean (pooled prevalence=42%; 95% CI: 18% to 65%) followed by the Western Pacific region (pooled prevalence=40%;95% CI: 26% to 54%). The results indicated a significant heterogeneity (I 2 =98.8%,P<0.05). Conclusion Our findings indicated that depression is high among gastric cancer patients. The findings suggest health authorities to provide specially designed social and psychological supportive care services, including screening for depression, among such patients. PROSPERO registration number CRD42020139836. ©